Lung Cancer
Metastasis or recurrent disease can be well managed by weekly paclitaxel
Published in Cancer Weekly, March 18th, 2003
According to a study from Spain, "Weekly paclitaxel was initially used to exploit the radio sensitizing properties of the drug. However, the observed improvement in therapeutic index with this regimen encouraged further use of weekly regimens, with and without radiotherapy, as a single agent or in combination with other regimens. Single agent weekly paclitaxel, at doses ranging from 50-200 mg/m2/week, has been associated with response rates of 23-56% with acceptable toxicity."
"Weekly paclitaxel has also been combined with carboplatin and vinorelbine in 2 drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-03-18)
More Articles from Cancer Weekly
- Breast Cancer
Scientists find 'stem cells' in human breast cancer - DNA Repair
Infertility and cancer linked to late-stage repair defects - Ewing Sarcoma
Chromosomal abnormalities have been detected in Ewing Sarcoma - Head and Neck Cancer
Laser light therapy seen as "magic bullet" for some throat and oral cancers - Tumor Staging
Researchers discovering new clues to treating cancer - Vaccine Safety
Occult orbital neuroblastoma detected after antitumor vaccine - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
